Immune Drug Beats Antidepressants, Psilocybin Phase 3 Wins, AI Therapy Trust Drops to 8%, Mindfulness May Increase Bias: 13 Essential Mindfulness & Mental Wellness Stories (May 31, 2026)
Mindfulness and mental wellness made dramatic headlines this week, from a landmark immune-system drug that outperformed standard antidepressants in treatment-resistant depression to back-to-back Phase 3 psilocybin wins that could reshape psychiatry. As mindfulness and mental wellness research accelerates across clinical labs, behavior science departments, and digital health platforms, the week of May 31, 2026 delivered … Read more
